We all know salvia based technology is not as accurate as urine based. I believe that is a fact. As such FDA approval may never be given unless SBN can convince the authority to view Oraline as a new category of detection that make it obvious that it is not in the same realm of urine based devices. One way to pursue this is to highlight that Saliva based detection is a front line device only to be used in conjunction with a urine based device for confirmation. Perhaps the sale of Oraline could find FDA tenure if it is sold with urine based devices only. Instead of marketing Oraline by itself it could be sold as an enhancement add on to SBN's urine devices. What are your thoughts guys and girls.
- Forums
- ASX - By Stock
- SBN
- fda
fda
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)